Page last updated: 2024-08-25

methotrexate and Aplasia Pure Red Cell

methotrexate has been researched along with Aplasia Pure Red Cell in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's3 (30.00)18.2507
2000's2 (20.00)29.6817
2010's2 (20.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
An, X; Huang, B; Shi, Y; Zhang, L1
Chen, D; Feldman, AL; He, R; Jevremovic, D; Morice, WG; Shi, M; Viswanatha, DS1
Chen, YY; Fan, L; Gale, RP; Li, JY; Liang, HJ; Qian, J; Qiao, C; Qiu, ZY; Wang, L; Wang, M; Wang, R; Wu, YJ; Xu, W1
Chen, J; Li, JP; Zhang, T; Zhong, J; Zhu, KE1
Kung, YY; Tsai, CY; Tsai, ST; Tsai, YY; Wu, TH; Yu, CL1
Antich Rojas, J; Balaguer, H; Cladera, A1
Breedveld, FC; den Ottolander, GJ; Janssen, HL; van Hoek, B; van Krieken, JH; van Laar, JM1
Go, RS; Li, CY; Phyliky, RL; Tefferi, A1
Hosoi, T; Sato, N; Shirafuji, N; Takaku, F; Takatani, O; Urabe, A1
Grechikhina, EN; Idel'son, LI; Kolesnikova, AS; Pivnik, AV; Ter-Grigorov, VS1

Other Studies

10 other study(ies) available for methotrexate and Aplasia Pure Red Cell

ArticleYear
Successful treatment of pure red cell aplasia induced by anti-PD-1 tslelizumab with low-dose methotrexate for metastatic urothelial cancer.
    Asian journal of surgery, 2023, Volume: 46, Issue:7

    Topics: Humans; Immunosuppressive Agents; Methotrexate; Neoplasms; Red-Cell Aplasia, Pure

2023
STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.
    Human pathology, 2018, Volume: 73

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Arthritis, Rheumatoid; Female; Humans; Leukemia, Large Granular Lymphocytic; Male; Methotrexate; Middle Aged; Mutation; Red-Cell Aplasia, Pure; STAT3 Transcription Factor; Treatment Outcome

2018
Methotrexate therapy of T-cell large granular lymphocytic leukemia impact of STAT3 mutation.
    Oncotarget, 2016, Sep-20, Volume: 7, Issue:38

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blood Sedimentation; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukemia, Large Granular Lymphocytic; Male; Methotrexate; Middle Aged; Mutation; Prednisone; Red-Cell Aplasia, Pure; Remission Induction; Sequence Analysis, DNA; STAT3 Transcription Factor; Time Factors; Treatment Outcome

2016
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:2

    Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; beta-Thalassemia; Blood Group Incompatibility; Busulfan; Child, Preschool; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasma Exchange; Red-Cell Aplasia, Pure; Remission, Spontaneous; Retrospective Studies; Risk Factors; Rituximab; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation

2007
Pure red cell aplasia in a man with RA.
    Scandinavian journal of rheumatology, 1997, Volume: 26, Issue:4

    Topics: Aged; Arthritis, Rheumatoid; Danazol; Humans; Male; Methotrexate; Red-Cell Aplasia, Pure; Sulfasalazine

1997
[Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
    Sangre, 1997, Volume: 42, Issue:3

    Topics: Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Chlorambucil; Cyclophosphamide; Cyclosporine; Doxorubicin; Humans; Hydrocortisone; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Vidarabine; Vincristine

1997
Severe hepatitis and pure red cell aplasia in adult Still's disease: good response to immunosuppressive therapy.
    Digestive diseases and sciences, 1999, Volume: 44, Issue:8

    Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Female; Hepatitis; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Prednisone; Red-Cell Aplasia, Pure; Still's Disease, Adult-Onset

1999
Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes.
    Blood, 2001, Jul-15, Volume: 98, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, T-Cell; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; T-Lymphocytes, Cytotoxic

2001
Treatment of pure red cell aplasia that is resistant to conventional immunosuppressive therapy with intermittent administration of methotrexate.
    Acta haematologica, 1989, Volume: 82, Issue:2

    Topics: Drug Resistance; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Red-Cell Aplasia, Pure

1989
[Remission in partial red cell aplasia achieved using a treatment with cyclosporin A].
    Terapevticheskii arkhiv, 1988, Volume: 60, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Combined Modality Therapy; Cyclosporins; Female; Humans; Methotrexate; Plasmapheresis; Prednisolone; Red-Cell Aplasia, Pure; Remission Induction; Splenectomy; Vincristine

1988